June 22, 2024
Microbiome Sequencing Service Market

Microbiome Sequencing Service Market Growth Owing to Rising Prevalence of Chronic Diseases

The microbiome sequencing service market involves sequencing and analysis of microbial communities like bacteria, viruses, fungi and protozoa found in and on the human body. Microbiome sequencing helps in identifying relationships between human health and microbes. Sequencing services offer profiling of microbiomes of stool, skin, oral cavity and urogenital tract. This gives insights into microbial compositions and helps understand mechanisms of various diseases.

The global microbiome sequencing service market is estimated to be valued at US$ 4.13 Bn in 2024 and is expected to exhibit a CAGR of 11% over the forecast period 2024 to 2031.

Key Takeaways

Key players: Key players operating in the Microbiome sequencing service market are Microbiome Insights Inc., Baseclear B.V., Clinical Microbiomics A/S, Mérieux NutriSciences Corporation, MR DNA, Zymo Research Corporation, Metabiomics Corp., uBiome, Inc., Microbiome Therapeutics Innovation Group, Locus Biosciences, Inc., OpenBiome, Shanghai Ruiyi Biotechnology Co., Ltd., Resphera Biosciences, LLC, Molzym GmbH & Co. KG, BioSpherex LLC, and Diversigen.

Key opportunities: Rising prevalence of chronic diseases like diabetes, cancer and gut disorders is driving research on human Microbiome Sequencing Service Market Demand. This is creating opportunities for market players to develop disease specific microbiome profiling services and diagnostics. Advances in next generation sequencing technologies is enabling high throughput and cost effective microbiome analysis.

Global expansion: Leading players are expanding their presence globally through partnerships and collaborations. They are also offering customized and cloud based data analysis solutions. Increasing clinical trials on microbiome therapies and fecal microbial transplants are prompting research institutes globally to use sequencing services.

Market drivers: A key driver for this market is the growing application of microbiome sequencing in prebiotic and probiotic product development. Understanding the effects of diet, antibiotics and other environmental factors on gut and other human microbiomes also aids development of personalized nutrition and treatment strategies. This is expected to further propel demand for microbiome profiling services.

PEST Analysis:

Political: In some countries, rules and regulations regarding the collection, storage and sharing of human microbiome data restrict the growth of the microbiome sequencing service market. However, supportive government initiatives and funding are helping drive innovation.

Economic: Rising healthcare expenditure and increasing focus on preventive healthcare is increasing the demand for personalized medicine using microbiome sequencing. The market is expected to grow steadily due to growing investments in R&D activities.

Social: Improving awareness about human microbiome and its role in various health conditions is enabling more individuals to opt for microbiome profiling tests. However, ethical and privacy issues still limit social acceptance of some applications.

Technological: Advanced DNA and RNA sequencing technologies are enabling high-throughput analysis of microbial communities in increasingly cheaper and faster ways. Continuous innovation in bioinformatics and computational biology is helping analyze massive genomic data sets to discover new insights. Multi-omics approaches are integrating microbiome data with other omics data.

North America is currently the largest market for microbiome sequencing services in terms of value, led by the US. This is due to high healthcare spending, presence of leading market players, and supportive government initiatives. Asia Pacific is anticipated to be the fastest growing regional market over the forecast period owing to rising healthcare expenditure, improving access to diagnostics, and growing middle-class population in countries such as China and India.

Europe also accounts for a sizeable share and is expected to witness steady growth. However, regulatory hurdles and ethical concerns are slowing commercial adoption in some parts of Europe. The market in Latin America, Middle East & Africa is still in the nascent stage but is projected to expand at a notable pace over the coming years.

*Note:
1. Source: Coherent Market Insights, Public Source, Desk Research
2. We have leveraged AI tools to mine information and compile it.